- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00459017
The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension
April 10, 2007 updated by: Sheba Medical Center
Despite knowledge regarding the importance of controlling patients' blood pressure (BP) only 30% of treated patients achieve BP goals.
Our objective was to determine the effect of frequent self measurements of BP in the patients' natural environment as a mean to improve BP control.
Our hypothesis was that frequent measurements of BP will reduce mean BP levels.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
150
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tel Aviv, Israel
- Kupat Holim Meuhedet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Signing an informed consent form
- Having a diagnosis of hypertension for more than one year according to patients'records.
- receiving at least one medication for hypertension
- A reasonable understanding of Hebrew
- An ambulatory state enabling regular visits to a primary physician in the community and self-measurement of hypertension using the electronic device
Exclusion Criteria:
- Lack of willingness to participate in the study.Known arrhythmia
- Malignant disease
- Poor understanding of Hebrew
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Meam blood pressure
|
Secondary Outcome Measures
Outcome Measure |
---|
Quality of life
|
Satisfaction
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yasmin Maor, MD, Sheba Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2002
Study Completion (Actual)
June 1, 2005
Study Registration Dates
First Submitted
April 10, 2007
First Submitted That Met QC Criteria
April 10, 2007
First Posted (Estimate)
April 11, 2007
Study Record Updates
Last Update Posted (Estimate)
April 11, 2007
Last Update Submitted That Met QC Criteria
April 10, 2007
Last Verified
April 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHEBA -02-2773-YM-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Portable blood pressure wrist manometer
-
Huawei Device Co., LtdCompleted
-
Osama Ali IbraheimCompleted
-
Yonsei UniversityCompletedGeneral AnesthesiaKorea, Republic of
-
University of ArkansasWithdrawn
-
Leo WangBTS InternationalCompletedHypertension | Efficacy of Wrist BPM MeasurementChina
-
Rutgers, The State University of New JerseyCompleted
-
Cairo UniversityCompletedHypertension | Diabetes | Hepatitis C, AcuteEgypt
-
University Hospital, LilleCompleted
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteRecruiting
-
Hacettepe UniversityCompletedEndotracheal Tube | Sore Throat | Cuff PressureTurkey